News from BioSensics
April 2015: GreatCall, the leader in creating mobile health and safety solutions for active aging, has added ActivePERS automatic fall detection technology from BioSensics to its 5Star urgent
response service. When GreatCall’s urgent response device detects a fall, an audible prompt notifies the user that a call will be made to 5Star urgent response agents. The call is identified as being automatically generated via fall detection and, as with all 5Star calls, a team of NAED-Certified Response Agents handles communication through the device and stays connected with the customer until the incident is resolved. “We are very pleased to add GreatCall to the list of partners for our fall detection technology,” said Dr. Joseph Gwin, BioSensics Vice President of Research and Development. “The waterproof, mobile, GreatCall Splash has had, and will continue to have, a significant impact on the safety, health and independence of older adults. We are proud to be a part of this effort.” See the full press release.
December 2014: BioSensics has been named by the Journal of mHealth to the Global Digital Health 100, recognizing the 100 most innovative mobile and digital healthcare companies in the World today! “This year has been amazing for digital health” said Matthew Driver, Managing Editor of The Journal of mHealth. “There are so many great companies producing really innovative and amazing products that are set to revolutionize healthcare delivery. We had a very difficult time narrowing the pool and selecting the final 100.” The Award represents 6 months of research by the editorial team at the Journal, who considered the offerings and innovations from over 1,500 different mobile and digital health companies worldwide, before selecting the final 100. Using 10 different quantitative and qualitative evaluation criteria including, disruptive impact, proof of concept, technology innovation, social value, execution of strategy, and industry integration, The Journal of mHealth editorial team has selected the 100 companies that demonstrate true innovation and the opportunity to disrupt the delivery of healthcare at scale.
November 2014: BioSensics and My911 are pleased to announce the integration of ActivePERS into the My911 mobile emergency management platform. My911 is a mobile engineering enterprise devoted to bringing safety & service to today’s mobile world. Their platform unites approved wireless sensors and meters into a single web based dashboard and archival toolset. Read More…
August 2014: BioSensics announces the official launch of ActivePERS™, an advanced personal emergency response and telemonitoring solution for seniors. ActivePERS features patented and clinically validated automatic fall detection algorithms developed with support from the National Institute of Health (NIH), and in collaboration with the University of Arizona Medical School and the Arizona Center on Aging. Other features of ActivePERS include continuous monitoring of physical activity and compliance alerts (that indicate if the sensor is not being worn). BioSensics plans to add its patented and clinically validated “Fall Risk Assessment” technology to ActivePERS before the end of the year.
July 2014: The U.S. Patent and Trademark Office has published the BioSensics patent for technologies to monitor adherence to prescribed footwear (U.S. Patent # 8,753,275). This patent, entitled Intelligent Device To Monitor And Remind Patients with Footwear, Walking Aids, Braces, or Orthotics, covers technology designed to alert patients and caregivers if the user is walking without using prescribed assistive devices. The technology is being developed and commercialized by BioSensics with partial funding from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
May 2014: Technology being developed by BioSensics and the University of Arizona Center on Aging was featured IEEE Pulse – A magazine of the IEEE Engineering in Medicine and Biology Society. The technology combines BioSensics wearable sensors with virtual reality-based games designed to improve balance and reduce the risk of falls among older adults with peripheral neuropathy. This collaborative project was funded by the National Institute on Aging.
February 2014: BioSensics is a now a member of the Qualcomm Life Ecosystem of medical devices and applications. Being part of this rapidly expanding ecosystem helps deliver BioSensics’ unique telehealth and aging-in-place solutions to a broad network of technology partners and customers.
February 2014: BioSensics technology for monitoring adherence to prescribed walking aids, footwear, braces, and orthotics was featured on Fox 11 News, Tuscon, AZ. This technology has been developed in collaboration with the University of Arizona Medical School with funding from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). In January 2014 BioSensics received Notice of Allowance for U.S. Patent Application No. 13/005548, which covers this technology.
January 2014: BioSensics, in collaboration with Beth Israel Deaconess Medical Center and Harvard Medical School, has received two Phase I SBIRs from the U.S. Army to develop orthopedic injury criterion and risk analysis software tools to assist in the design of military equipment. The objective of the first project is to develop injury criteria and risk analysis software tools for 1) repetitive, forceful one and two hand shoulder push/pull motions performed while operating military equipment, and 2) risk of neck injury from loads sustained while wearing head supported mass. These projects reflect the ongoing commitment of BioSensics to perform innovative research and development to meet the evolving needs of our Armed Forces.
January 2014: Virtual reality based fall prevention training for seniors being developed by BioSensics and the University of Arizona Center on Aging was featured on CHCH TV in Ontario, Canada. This technology for in-home use combines BioSensics wearable sensors with video games designed to improve balance and reduce the risk of falls. It is expected to hit the market in 2016. This collaborative project was funded by the National Institute on Aging.
December 2013: Technology being developed by BioSensics and the University of Arizona Center on Aging was featured in a news story from the American Podiatric Medical Association. The technology combines BioSensics wearable sensors with virtual reality-based games designed to improve balance and reduce the risk of falls among older adults with peripheral neuropathy. This collaborative project was funded by the National Institute on Aging.
December 2013: ActivePERS™ automatic fall detection technology was featured on the Aging In Place Technology Watch website, a leading market research firm providing analysis on technologies that enable boomers and seniors to remain in their home of choice longer. ActivePERS™ was highlighted in the list of ten technologies from the 2013 mHealth Summit.”
December 2013: BioSensics will be showcasing ActivePERS™ at the mHealth Summit in Washington DC, December 8-11. ActivePERS™ is the only Personal Emergency Response pendant with clinically validated and patented automatic fall detection algorithms. It was developed with support from the National Institutes of Health. ActivePERS™ technology is quickly becoming the gold standard in automatic fall detection, as evidenced by its rapid adoption from leading edge companies specializing in home health monitoring solutions that enable seniors to live more safely and independently from their home. ActivePERS™ also features non-compliance alerts that continuously monitor if the device is being worn by the patient, as well as step counting that can be reported hourly or daily.
November 2013: BioSensics technology for monitoring patient adherence to prescribed footwear was featured in the November 11th episode of Your Life Redefined on RLTV. This episode focused on “Smart Medicine – Keeping America Active” and highlighted BioSensics wearable technologies, including a patented sensor technology for monitoring adherence to prescribed diabetes footwear that can assist in treating and preventing pressure ulcers on the feet.
September 2013: Performing a gait analysis has never been more convenient! Customers who have purchased the LEGSys™ software now have free access to the LEGSys™ App for Android tablets. Our sleek, easy to navigate, optimized interface puts all the features of a gait lab in the palm of your hand, adding a new dimension of portability without sacrificing functionality. Customized reports can be exported as PDF files and emailed from your Android device, providing a seamless transition for those PC users seeking the convenience of a tablet.
August 2013: BioSensics was awarded a $398,000 SHIFT SBIR grant from the NIH National Institute on Aging to develop a virtually supervised web-based home exercise technology for older adults. This collaborative project with the University of Arizona aims to improve mobility and reduce falls by enabling in home strength and balance training via an interactive web application that includes an on-screen ‘user avatar’ that mimics the users movements based on real-time data from wearable sensors.
August 2013: For immediate release: BioSensics is pleased to announce a partnership with Care Technology Systems, a health technology company committed to delivering innovative monitoring solutions for seniors. The ActivePERS™ fall detection pendant by BioSensics is now offered as a part of the QuietResponse™ monitoring system by Care Technologies Systems. QuietResponse was designed for senior living facilities and provides constant attention to resident safety and staff efficiency using a variety of wireless sensors and a cloud-based, algorithm-driven engine that sends alerts to staff if anything is outside of a normal range for each resident. The ActivePERS fall detection pendant is a water-resistant pendant with a one year battery life that allows seniors to call for help with the push of a button and automatically detects falls using patented fall detection algorithms based on 10 years of research supported in part by the National Institutes of Health. Read More…
May 2013: BioSensics was awarded a $150K Phase I SBIR grant from the U.S. Department of Defense to develop an objective method for pain detection. The Multimodal Objective Pain Assessment Sensor System (MoPASS™) will consist of wireless wearable sensors that monitor multiple indicators of pain and provide a single pain intensity score for patients who cannot reliably self-report and are, therefore, at a significantly higher risk for inadequately managed pain. This project reflects BioSensics continued commitment to developing novel wearable sensor systems for healthcare and medical applications.
April 2013: For immediate release: BioSensics is pleased to announce a partnership with Aventyn, Inc., a health technology company committed to delivering innovative, standards based, secure core to cloud clinical information processing solutions and services. BioSensics and Aventyn will be offering new and improved PAMSys™ sensors with remote, internet cloud based data access through Aventyn® innovative Vitalbeat remote patient monitoring system. This joint solution will enable hospitals, physician offices, university medical centers, home care providers, hospices and clinical researchers to remotely monitor patient physical activity and capture relevant changes in activities of daily living. Read More…
May 2013: BioSensics will be exhibiting at the American Telemedicine Association (ATA) annual conference from May 5th to 7th in Austin, TX, USA. BioSensics will feature PAMSys™ and showcase new technologies that will be released in early 2014. Specifically we will be highlighting our Active Personal Emergency Response System featuring our patented fall detection technology. If you are planning to attend the ATA conference, please come and visit BioSensics at booth 1411. To arrange a meeting with BioSensics at the conference please email: firstname.lastname@example.org
April 2013: BioSensics was awarded a $397,000 SHIFT SBIR grant from the NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development to develop and commercialize an interactive telehealth monitoring and biofeedback system to promote physical activity, pressure relief maneuver performance, and self-management among wheelchair users. This collaborative project with Rancho Los Amigos National Rehabilitation Center (Downey, CA) aims to address the significant and costly secondary complications of chronic disabilities that necessitate wheelchair usage, such as pressure ulcers, obesity, diabetes, osteoporosis, and cardiovascular co-morbidities.
February 2013: BioSensics was featured in a University of Arizona News story on new technology to improve adherence to prescribed footwear. This news story highlights one of several collaborative new developments between BioSensics and the Interdisciplinary Consortium on Advanced Motion Performance at the University of Arizona.
January 2013: BioSensics exhibited at the American Physical Therapy Association (APTA) annual Combined Sections Meeting in San Diego, CA, USA. BioSensics presented LEGSys™ and BalanSens™ at TechnoPalooza inside the Exhibit Hall at CSM. TechnoPalooza aims to foster exchanges among clinicians, academicians, researchers, developers, and vendors to discover creative ways to apply technology in rehabilitation settings.
December 2012: University of Arizona press releases highlighted two collaborative projects with BioSensics including a new technology aimed at boosting patient adherence to prescribed footwear and the co-development of a wearable pendant that can detect an elderly person’s risk for falling and automatically alert medical personnel when a fall has occurred.
December 2012: BioSensics has been selected to participate in the 2012-2013 NIH SBIR Commercialization Assistance Program (CAP) in the Commercialization Training Track (CTT). CAP is a specialized technical assistance program for SBIR/STTR Phase II awardees. BioSensics was one of only sixty 60 SBIR/STTR Phase II awardees selected for this competitive program. CAP is designed to help promising small life science companies develop their commercial businesses and transition their SBIR/STTR developed technologies into the marketplace.
November 2012: BioSensics received a SBIR Phase 1 Commercialization Assistance Award from the National Institutes of Health. The award will support marketing research efforts related to a Phase I T2 SBIR grant from the National Institute on Aging. The goal of this project is to develop a novel tool for rehabilitation that combines BioSensics wearable sensor technologies with virtual reality-based games designed to promote motor learning and improve anticipatory and coordination strategies during obstacle crossing and altered walking. The SBIR Niche Assessment Program is a nationwide program funded by the National Institutes of Health to help jump-start an SBIR Phase I awardee’s commercialization efforts. Services are provided by Foresight Science and Technology of Providence, RI.
October 2012: BioSensics was featured in MobiHealthNews, the leading provider of news, commentary, online events and research for the global mobile health community. The story, by Padma Nagappan, highlights the fall detection and fall risk assessment features of PAMSys™.
September 2012: BioSensics was featured in Motion Interface Corner, an eNewsletter from InvenSense. InvenSense is a global leader in motion tracking devices for consumer electronics. InvenSens components power the wireless BioSensics Motion Sensor that will be featured in the newest versions of LEGSys™ and BalanSens™ to be released in October, 2012.
August 2012: BioSensics was awarded a $150K Phase I T2 SBIR grant from the National Institute on Aging to develop a novel tool for rehabilitation that combines BioSensics wearable sensor technologies with virtual reality-based games designed to promote motor learning and improve anticipatory and coordination strategies during obstacle crossing and altered walking. This is a collaborative project with the Center on Aging and the Medical School at the University of Arizona.
August 2012: BioSensics was awarded a $1.2M Phase II STTR grant from the National Institute on Aging to develop a portable device for telecare monitoring of elderly people. This is a collaborative project with the Center on Aging and the Medical School at the University of Arizona. As a part of the project, BioSensics and its partners will extend and clinically evaluate the capabilities of PAMSys™ for automatic fall detection and objective assessment of fall risk based on the data gathered during activities of daily living.
August 2012: BioSensics was awarded a $25,000 grant from The Center for Translation of Rehabilitation Engineering Advances and Technology (TREAT). TREAT is part of the National Institutes of Health (NIH) R24 network of rehabilitation research resource centers. TREAT focuses on technology transfer and comparative effectiveness research and is funded through the Eunice Kennedy Shriver National Institute of Child Health and Human Development. The award supports the development of the iProsthetix™ sensor system for lower-limb prosthesis. This is an ongoing DoD funded development at BioSensics targeted for commercialization in 2014.
June 2012: The U.S. Patent and Trademark Office has published the BioSensics patent for algorithms for physical activity monitoring, risk of fall assessment and automatic fall detection. (U.S. Patent # 8,206,325). This patent, entitled Ambulatory System for Measuring and Monitoring Physical Activity and Risk of Falling and for Automatic Fall Detection, covers the advance algorithms that enable PAMSys™ to detect posture and postural transitions, assess the wearer’s gait, automatically detect falls, and assess the wearer’s risk of falling.
June 2012: BioSensics releases PAMWare™ v1.5, which includes new automated algorithms and critical upgrades. New processing algorithms include fully-automated physical activity analysis, automatic fall detection, and visualization of ECG signals for the new PAMSys-ECG™ platform. In addition, PAMWare™ v1.5 will run more than two times faster and use 50% less RAM then prior PAMWare™ releases. To receive the latest version of PAMWare™, please email email@example.com
May 2012: BioSensics is one of the sponsors of BSMPG 2012 Summer Seminar, May 19-20, Boston. BioSensics is sponsoring one talk given by Dr. Bruce Williams, as a part of the “Sports Medicine and Rehabilitation Track”.
May 2012: The NorthFace is using a custom BioSensics sensor solution for measurement of athletic performance and to design better garments and apparel. Custom solutions from BioSensics include a variety of wireless sensor networks to measure activity, humidity, temperature and other physiological signals and parameters.
April 2012: BioSensics LLC will be exhibiting at the MIT Enterprise Forum In-NOW-vation Showcase & Celebration. The exhibition will be hosted April 26th, 6-8:30 p.m. at Microsoft NERD.
March 2012: PAMSys™ and BalanSens™ are featured in a Today in PT article titled “Measuring Progress” by Bonnie Benton. The article appeared in the March 2012 Edition of Today in PT and highlights the importance of outcome measurements in clinical and PT practice.
March 2012: BioSensics was awarded a collaborative grant from the National Institute on Disability and Rehabilitation Research to develop a novel system for monitoring and providing automatic feedback to wheelchair users. The proposed technology can provide a unique means for persons with SCI to collaborate with their clinicians to promote healthy lifestyle choices throughout the lifespan, and a reliable and robust tool for preventing complications. The project is part of the Spinal Cord Injury (SCI) Model Systems initiative and is lead by Ranchos Los Amigos Rehabilitation Center. Other partner institution in the project are the Kentucky SCI Research Center at the University of Louisville and Spaulding-Harvard SCI Research Center.
January 2012: BioSensics will be exhibiting at the American Physical Therapy Association’s (APTA) annual Combined Sections Meeting conference in Chicago, IL, USA. BioSensics will present live demonstrations of PAMSys™, BalanSens™ and LEGSys™ platforms and showcase the new technologies and platforms that will be released in early 2012. The APTA CSM will be taking place February 8th-11th, in Chicago, IL, USA. Please come and visit BioSensics’ booth (Booth # 867).
To arrange a meeting with BioSensics at APTA please email: firstname.lastname@example.org
January 2012: BioSensics was awarded a $150,000 Phase I SBIR grant from the US Army Medical Research and Materiel Command. In this interdisciplinary project, BioSensics has partnered with Ranchos Los Amigos Rehabilitation Center to develop a rehabilitative technology for monitoring and measuring metabolic demands and energy expenditure in lower extremity amputees with prosthetics.
November 2011: BioSensics will present and demo its different platforms for measurement of physical activity, human motion, balance and gait at TEDx Cambridge at Harvard. TEDx is a program of local, self-organized events that bring people together to share a TED-like experience. The presentation is at Northwest Building of Harvard University on Saturday November 19.
October 2011: BioSensics is selected as one of the exhibitors for the 32nd Mass Innovation Night. The exhibition will be held at the Mass Challenge center on November 9. For further information about this event, please click here.
October 2011: BioSensics will be exhibiting at the Wireless Health 2011 Conference Conference and presenting live demonstrations of the PAMSys™ and LEGSys™ platforms. The Wireless Health 2011 conference will be taking place October 10th – 13th, in San Diego, CA, USA. To set up a meeting with BioSensics at Wireless Health 2011, please email: email@example.com
About Wireless Health 2011: The Wireless Health 2011 annual conference series convenes the vanguard international research communities in Wireless Health technology and medical research with the rapidly expanding Wireless Health product and service industry, government leadership and policy makers.
September 2011: BioSensics LLC was approved for the National Institute of Health’s SBIR Niche Assessment Program. Technology Niche Analyses™ (TNA™) are provided by Foresight Science and Technology for only 100 NIH SBIR Phase I awardees. The National Institute of Health’s SBIR Niche Assessment Program is a nationwide program funded by NIH to help jump-start an SBIR Phase I awardee’s commercialization efforts. Services are provided by Foresight Science and Technology of Providence, RI. These analyses assess potential applications for a technology.
August 2011: BioSensics will present a Workshop In the EMBC 2011 Conference (August 30-Sept 3, Boston) to demonstrate BioSensics products. The Workshop titled “An Open and Extensible Wearable Research Platform” will be held on Wednesday August 31 at 13:00 – 14:30. This workshop will be of interest to biomedical researchers and students interested in wearable sensors, biomechanics, and activity classification.
August 2011: BioSensics was awarded a $395,000 NIH grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). In this interdisciplinary SHIFT SBIR project, BioSensics has partnered with the Rosalind Franklin University of Medicine and Science to develop a technology to monitor and measure patient adherence to therapeutic footwear.
May 2011: BioSensics received a grant from Massachusetts Life Sciences Center to support internship opportunities through the 2011 Internship Challenge program. This program is a workforce development program that is focused on enhancing the talent pipeline for Massachusetts companies engaged in life sciences.
February 2011: PAMSys™ was featured on a local CBS news channel in Pennsylvania (WTAJ) on February 10th. In a research study led by the University of Arizona, the PAMSys™ technology is used to measure and record the type of activity, the duration of the activity and its intensity and to correlate specific types of activity that may raise the risk for foot complications in diabetics.
Read more and see the video…
February 2011: PAMSys™ was featured in the local abc TV channel’s website (WSOC-TV 9) in Charlotte, North Carolina on February 4th as well as the TV channel’s website. Read more…
November 2010: BioSensics was awarded the Qualifying Therapeutic Discovery grant from the Federal government to advance the development of novel sensor-based biofeedback and health monitoring systems, including PAMSys™ and IntellaPAM™. The $113,000 grant was awarded by the Internal Revenue Service and the U.S. Department of Health and Human Services as part of the Qualifying Therapeutic Discovery Project Program (QTDP), which was established under the Patient Protection and Affordable Care Act of 2010. The QTDP was created to support innovative, therapeutic projects that result in new therapies, reduce long-term healthcare costs, address unmet medical needs, or significantly advance the goal of curing cancer.
October 2010: BioSensics released the wireless version of BalanSens™. The system is highly portable, easy-to-use, comfortable for the user, usable in virtually all clinical environments and requires no dedicated space.
September 2010: PAMSys™ was featured on the Diabetic Foot blog, which covered ongoing research in diabetic care in the University of Arizona Department of Surgery. Dr. David Armstrong, the Lead PI of the project, said about PAMSys™: “It can assess not just the steps that we take, but many other things. It can measure if you are standing or sitting, jumping or running, lying down on your stomach or your back. We are able to gauge, with highly sensitive equipment, what’s going on with the foot and rest of the body based on subtle movements that occur in the trunk”.
September 2010: PAMSys™ was featured on the September 9th issue of PM News (The voice of podiatrists). PAMSys™ is being used in the research led by the University of Arizona Department of Surgery to monitor activity among diabetics with foot wounds. The study is aimed to determine the role activity plays in the formation of sores to better understand how to prevent wounds from occurring. See this issue of PM News…
September 2010: The research carried out using PAMSys™ technology and supported in part by BioSensics STTR grant is published in the journal of Diabetic Care. In this study, PAMSys™ was used to monitor spontaneous daily physical activity in diabetic peripheral neuropathy (DPN) patients and to examine both walking and standing activities as important foot-loading conditions. Thirteen DPN patients were asked to wear a PAMSys™ motion sensor for 48 hours. Body postures (sitting, standing, lying) and locomotion (walking, number of steps, postural transition) were extracted. See the abstract…
August 2010: BioSensics released a new design for the PAMSys™ motion sensor, which is thinner and lighter. The new PAMSys™ motion sensor is 5.1 cm x 3 cm x 1.6 cm (2 in x 1.2 in x 0.6 in) and weighs only 20 gr (0.7 oz.).
August 2010: PAMSys™ is being used at Northeastern Physical Therapy department to study the physical activity of people post-stroke.
July 2010: The research carried out using PAMSys™ technology and supported in part by BioSensics STTR grant from NIH was selected between the Outstanding Poster Abstracts by American Podiatric Medical Association (APMA).
June 2010: PAMSys™ is being used in a multi-national research aimed to use body worn sensor technology for improving diabetic care. Read more…
May 2010: A research study by Rosalind Franklin University using PAMSys™ technology established the linkage between physical activity and foot ulcer development. The study will be presented at the American Diabetes Associations’ 2010 meeting, and was among the only eight submissions selected for oral presentation. The study also ranked amongst the highest scoring abstracts in the Foot Care/Lower Extremities category and received the Marvin Levin Travel Scholarship.
March 2010: BioSensics released PAMSys™ (Physical Activity Monitoring System). This unique, patent-pending technology allows continuous monitoring of physical activity for up to 5 days.
September 2009: BioSensics received a grant from the National Institute on Aging (NIA) to develop IntelAPAM™ (Intelligent Autobiofeedback and Physical Activity Monitoring System), a reliable and interactive system for telecare of persons with minor cognitive impairments (MCI), such as Traumatic Brain Injury (TBI), Post Traumatic Stress Disorder (PTSD), and short-term memory loss.
March 2009: BioSensics received a grant from the the National Institute on Aging (NIA) to develop a novel technology for elderly care. This project will develop and commercialize a novel ambulatory system for elderly care based on the body-fixed-sensor technology. The proposed technology integrates three key features and capabilities which are of significant importance for elderly care and monitoring the state of mental and physical health; 1) long-term physical activity monitoring, 2) objective assessment of risk of falling, 3) Automatic fall detection.
January 2009: BioSensics released PAMSys™ (version beta). PAMSys™ devices can continuously monitor physical activity for up to 2 days.
August 2008: BioSensics partners with Rosalind Franklin University to develop sensor-based technologies for elderly and diabetic care.